Analyst Ratings for Atea Pharmaceuticals (AVIR)

AVIR Rating Summary

  |   Expand Research on AVIR
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/13/2024 Morgan Stanley Matthew Harrison Upgrade Equalweight
(Underweight)		 6.88
(2.00)		 3.37
(5.89)		 74.78% Details
8/10/2023 JPMorgan Eric Joseph Downgrade Underweight
(Neutral)		 N/A
(N/A)		 3.41
(5.89)		 72.73% Details